Industry Insights

  1. How A New Cell Therapy Platform Helps Scale Up Manufacturing To Reach More Patients
    9/6/2018

    Cell therapy manufacturing has been a complex, challenging and costly process, but a new manufacturing solution seeks to change that

  2. The Big (Bio) Freeze
    9/4/2018

    Reproducible freezing and thawing is critical for successful cell therapies. GE Healthcare’s G. John Morris explains why.

  3. Industrializing Cell Therapy
    9/4/2018

    As cell therapies continue to transition from the discovery stage to therapeutic reality, with further approvals sure to come, new challenges are emerging.

  4. An Overview Of ISCT 2018 In Montreal
    9/4/2018

    Once upon a time people wondered whether cell therapies would make it. Now, the industry is surging forward with new questions and even more creative solutions – takeaways from ISCT 2018, Montreal.

  5. Provocative Questions For CAR T Cell Therapy Scientists
    8/31/2018

    The FDA approval of two cell therapies is a major milestone on an exciting journey of discovery. What are some of the important questions still being explored?

  6. How A New Factory-In-A-Box Is Helping Scale Up Manufacturing Of Viral Vector Based Therapies To Reach More Patients
    8/31/2018

    Manufacturing viral vector-based therapies such as vaccines and gene and cell therapies is complex, but a new manufacturing solution helps solve those challenges.

  7. The Future Of Precision Medicine In China
    8/30/2018

    China is quickly becoming a world leader in biopharma, with rapid build-out of gene and cell therapy production capacity and a robust pipeline of drugs in development.